Characteristic methylation profile in CpG island methylator phenotype‐negative distal colorectal cancers
暂无分享,去创建一个
Lanlan Shen | K. Matsuo | Y. Yatabe | Y. Kondo | H. Osada | Y. Sekido | H. Murakami | T. Tani | M. Tajika | K. Yamao | A. Sawaki | Y. Kanemitsu | T. Hirai | Yasuyuki Okamoto | M. Fujii | K. Shinjo | K. Komori | Tsuneya Nakamura | Byonggu An | J. Issa | Keiko Shinjo
[1] M. Toyota,et al. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma. , 2009, Cancer research.
[2] Martin Dugas,et al. High-Resolution Genomic Copy Number Profiling of Glioblastoma Multiforme by Single Nucleotide Polymorphism DNA Microarray , 2009, Molecular Cancer Research.
[3] J. Issa,et al. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas. , 2008, Carcinogenesis.
[4] J. Issa. Colon Cancer: It's CIN or CIMP , 2008, Clinical Cancer Research.
[5] Yi Guo,et al. An Sp1/Sp3 Binding Polymorphism Confers Methylation Protection , 2008, PLoS genetics.
[6] S. Ogino,et al. LINE‐1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer , 2008, International journal of cancer.
[7] S. Kakar,et al. Proximal and distal colorectal cancers show distinct gene-specific methylation profiles and clinical and molecular characteristics. , 2008, European journal of cancer.
[8] M. Kloor,et al. Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer. , 2008, Gastroenterology.
[9] Minoru Toyota,et al. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer , 2007, Proceedings of the National Academy of Sciences.
[10] W. Grady. CIMP and colon cancer gets more complicated , 2007, Gut.
[11] Li Zhang,et al. Genome-Wide Profiling of DNA Methylation Reveals a Class of Normally Methylated CpG Island Promoters , 2007, PLoS genetics.
[12] P. Gimotty,et al. Application of a BRAF pyrosequencing assay for mutation detection and copy number analysis in malignant melanoma. , 2007, The Journal of molecular diagnostics : JMD.
[13] Pang-Kuo Lo,et al. HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition. , 2007, Cancer research.
[14] T. Ushijima. Epigenetic field for cancerization. , 2007, Journal of biochemistry and molecular biology.
[15] Leopoldo Sarli,et al. Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis , 2007, International Journal of Colorectal Disease.
[16] M. Loda,et al. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies , 2006, Gut.
[17] P. Laird,et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer , 2006, Nature Genetics.
[18] S. Baylin,et al. Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.
[19] J. Issa. Optimizing therapy with methylation inhibitors in myelodysplastic syndromes: dose, duration, and patient selection , 2005, Nature Clinical Practice Oncology.
[20] Gary L Rosner,et al. Tumour vasculature: On the verge of collapse , 2005, Nature Reviews Cancer.
[21] Shuji Ogino,et al. Molecular Alterations in Tumors and Response to Combination Chemotherapy with Gefitinib for Advanced Colorectal Cancer , 2005, Clinical Cancer Research.
[22] M. Toyota,et al. CIMP, at last. , 2005, Gastroenterology.
[23] J. Issa. CpG island methylator phenotype in cancer , 2004, Nature Reviews Cancer.
[24] K. Kinzler,et al. Cancer genes and the pathways they control , 2004, Nature Medicine.
[25] J. Issa,et al. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. , 2004, Nucleic acids research.
[26] K A Baggerly,et al. Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. , 2003, BioTechniques.
[27] F. Guarner,et al. Gut flora in health and disease , 2003, The Lancet.
[28] B. Iacopetta. Are there two sides to colorectal cancer? , 2002, International journal of cancer.
[29] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[30] Michael J. Terry,et al. A comprehensive catalog of CpG islands methylated in human lung adenocarcinomas for the identification of tumor suppressor genes , 2002, Oncogene.
[31] S. Clark,et al. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells , 2002, Oncogene.
[32] S. Sukumar,et al. Compromised HOXA5 function can limit p53 expression in human breast tumours , 2000, Nature.
[33] David Joseph,et al. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer , 2000, The Lancet.
[34] S. Baylin,et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. , 1999, Cancer research.
[35] J. Herman,et al. CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[36] Peter A. Jones,et al. Cancer-epigenetics comes of age , 1999, Nature Genetics.
[37] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[38] A. Børresen-Dale,et al. Different genetic pathways to proximal and distal colorectal cancer influenced by sex‐related factors , 1997, International journal of cancer.
[39] Stefan U Kass,et al. DNA methylation directs a time-dependent repression of transcription initiation , 1997, Current Biology.
[40] K. Kinzler,et al. Lessons from Hereditary Colorectal Cancer , 1996, Cell.
[41] S. Clark,et al. High sensitivity mapping of methylated cytosines. , 1994, Nucleic acids research.
[42] S. Baylin,et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon , 1994, Nature Genetics.
[43] E. Wynder,et al. Environmental dietary factors in colorectal cancer some unresolved issues , 1992, Cancer.
[44] J. Bufill,et al. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. , 1990, Annals of internal medicine.
[45] D. Slaughter,et al. “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin , 1953, Cancer.